MedTrace Logo

Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors

NCT02957357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11314

Last updated 2021-10-20

Study results available
· View outcomes & findings →

Summary

Through this study, the investigators seek to identify the benefits (improved survival) and harms (more procedures, more treatment, side effects, and quality-of-life impact) from different surveillance frequencies-every three vs. six vs. 12 months. Using the National Cancer Database and quality-of-life data from a large group of prostate cancer survivors, the investigators aim to compare survival, procedures/tests, treatments, and side effects in prostate cancer survivors who are followed with alternative surveillance frequencies and compare quality-of-life outcomes. The overall goal of the study is to provide high-quality data that will allow development of a personalized, risk-based tailored approach to post-treatment surveillance for prostate cancer.

Conditions

  • Cancer of Prostate
  • Cancer of the Prostate
  • Prostate Cancer
  • Prostatic Cancer

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Alliance Foundation Trials, LLC.

    lead OTHER

Principal Investigators

  • Ronald Chen, MD, MPH · University of North Carolina, Chapel Hill

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2019-01-31
Completion
2019-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02957357 on ClinicalTrials.gov